Tpoxx

DRUG2 trials

Sponsors

SIGA Technologies

Conditions

Smallpox

Phase 3

Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days

CompletedNCT04971109

SIGA TechnologiesSmallpox

Start: 2022-03-29End: 2023-05-12Updated: 2026-09-11

Phase 4

Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG

CompletedNCT04392739

SIGA TechnologiesSmallpox

Start: 2019-07-19End: 2019-12-05Updated: 2026-09-11